Commure has closed a $70 million round at a $7 billion post-money valuation, led by General Catalyst with participation from Sequoia Capital, Morgan Stanley, and Kirkland & Ellis. The valuation is the headline, but the number that matters to anyone shipping agents in production is operational: Commure says its autonomous agents now complete more than 85% of end-to-end revenue cycle management (RCM) work without human intervention.
The deployment footprint is the story
This is not a pilot. Commure's platform runs across 500+ healthcare organizations and 3,000+ sites of care, including 130+ of the nation's largest health systems — HCA Healthcare, Tenet Healthcare, and Willis Knighton Health among the named customers. The company processes tens of billions of dollars in annual claims and touches tens of millions of appointments a year, while orchestrating across 60+ EHR platforms.
That scale is the moat, not the model. RCM is a fragmented, integration-heavy workflow where the hard part is not reasoning but connecting to dozens of incompatible record systems and payer interfaces. A vendor that has already wired into 60-plus EHRs and the back offices of HCA and Tenet has a distribution advantage that a better foundation model alone cannot replicate.
Why RCM is a clean target for agents
Revenue cycle management is one of the few enterprise workflows with a crisp, dollar-denominated reward signal: a claim is either paid or denied. That makes it far more tractable for agentic systems than open-ended knowledge work, because correctness is measurable and the feedback loop is fast. Coding, claim submission, denial follow-up, and payer-rule navigation are repetitive, rules-bound, and expensive — exactly the profile where autonomous agents can show hard ROI.
The architecturally interesting piece is what Commure calls a shared clinical intelligence layer — a cross-customer system that interprets denial patterns and navigates payer rules and alternative-payment-model guidelines. Pooling signal across 500+ organizations means each new denial reason or payer policy change improves the agents for everyone, a network effect that single-tenant deployments cannot match.
What it signals for enterprise AI
General Catalyst CEO Hemant Taneja characterized the bet as deploying "a robust system of autonomous agents" to run administrative workloads in modern ways. The capital is earmarked to extend the intelligence layer, scale RCM and practice-management tools into specialty practices and integrated delivery networks, and push into global markets.
The takeaway for builders: the durable enterprise-agent businesses emerging in 2026 are not the ones with the flashiest demos, but the ones embedded deep enough in a workflow to be measured in cash collected. An 85% no-touch rate on billions in claims is the kind of metric that survives an AI-spending correction — and it is the bar incumbents now have to clear.
